Top news coverage from the NFID 18th Annual Conference on Vaccine Research, held on April 13-15, 2015 in Bethesda, MD:
- 3 key lessons industry leaders have learned from the latest Ebola crisis (BioPharmaDive)
- Video: Assessment of vaccine safety, efficacy critical after introduction (Healio Infectious Disease News)
Featuring Kathleen M. Neuzil, MD, MPH, PATH - Video: D.A. Henderson, MD, honored for career in vaccine-preventable diseases (Healio Infectious Disease News)
Featuring D.A. Henderson, MD, Johns Hopkins University - Video: Effectiveness of inactivated vs. live flu vaccine currently unclear (Healio Infectious Disease News)
Featuring Richard K. Zimmerman, MD, University of Pittsburgh - HBV vaccine unaffected by type 2 diabetes (Diabetes in Control)
Featuring Andrew Trofa, MD, GlaxoSmithKine - Health care workers show preference for intradermal flu vaccine (Healio Infectious Disease News)
Featuring Julia B. Garcia-Diaz, MD, Ochsner Medical Foundation - LAIV more effective 1 year after IIV (Healio Infectious Disease News)
Featuring Herve Caspard, MedImmune - Video: New data on vaccines and vaccination at ACVR 2015 (Healio Infectious Disease News)
Featuring Bruce G. Gellin, MD, MPH, National Vaccine Program Office, US Department of Health and Human Services - Providers need to continually promote HPV vaccine to parents (Healio Infectious Disease News)
Featuring Beth Auslander, PhD, University of Texas Medical Branch - Tdap appears safe for pregnant women, infants (Healio Infectious Disease News)
Featuring Abbey B. Berenson, MD. PhD, University of Texas Medical Branch - Transparency key to increasing vaccination rates (Healio Infectious Disease News)
Featuring Natasha S. Crowcroft, MD, Public Health Ontario
Mark your calendars for the 19th Annual Conference on Vaccine Research scheduled for April 18-20, 2016 in Baltimore, MD. To receive updates about upcoming conferences, subscribe to NFID Updates.
To join the conversation, follow us on Twitter (@nfidvaccines) using the hashtag #ACVR, like us on Facebook, and join the NFID Linkedin Group.
